This company is not actively trading or the ticker does belong to another company in our database now.
Insider Roster
- Henry Blynn, Chief Operating Officer, 2026-07-24
- John Michael Kazley, Chief Executive Officer, 2026-06-18
- Ernest Michael Anderson, Large Shareholder, 2026-06-18
- Framework Ventures Iv Gp Llc, Large Shareholder, 2026-06-18
- Vance Spencer, Large Shareholder, 2026-06-18
- Framework Ventures Management Llc, Large Shareholder, 2026-06-18
- L.p. Iv Ventures Framework, Large Shareholder, 2026-06-18
- R01 Capital Manager Llc, Large Shareholder, 2026-06-18
- R01 Capital Llc, Large Shareholder, 2026-06-18
- R01 Fund Lp, Large Shareholder, 2026-06-18
- E. Paul Freiman, Director, 2026-04-21
- Yenyou Zheng, Director, 2026-04-09
- Tommy Law, Chief Financial Officer, 2026-04-08
- Swan Sit, Director, 2026-04-02
- E. David Lazar, Large Shareholder, 2026-01-30
- Poplar Point Capital Partners Lp, Large Shareholder, 2025-04-15
- Poplar Point Capital Gp Llc, Large Shareholder, 2025-04-15
- Poplar Point Capital Management Llc, Large Shareholder, 2025-04-15
- Jad Fakhry, Large Shareholder, 2025-04-15
- Julie Garlikov, Director, 2024-05-31
- Mijia Wu, Director, 2024-05-31
- Yongxiang Zheng, Director, 2024-05-31
- D. Andrew Jones, Cfo, 2023-02-17
- Audrey Kunin, Chief Product Officer, 2022-12-07
- Jeffrey Kunin, President, Dermadoctor, Llc, 2022-12-07
- Justin Hall, Ceo, Gc and Director, 2022-09-17
- Xinzhou Li, Large Shareholder, Director, 2021-05-25
- Wang Xu, Neo - Sr Mgr and Controller, 2020-08-24
- Xiaopei Wang, Other, 2020-08-24
- Ping Jian Fu, Large Shareholder, 2020-08-04
- Erik Todd Zavodnick, Director, 2019-10-30
- Philip Jason Raleigh, Interim Cfo and Treasurer, 2019-10-28
- J Gail Maderis, Director, 2019-10-28
- M Mark Sieczkarek, Director, 2019-10-28
- Pioneer Pharma (Hong Kong) Co Ltd, Large Shareholder, 2019-06-14
- Joseph John Mcgovern, Int Pres, Ceo, Cfo & Treasurer, 2018-10-11
- Yonghao Ma, Director, 2018-06-04
- Yanbin Liu, Director, 2018-06-04
- J Lewis Stuart, Chief Commercial Officer, 2018-01-08
- J Thomas Paulson, Cfo, 2017-01-26
- Xiaoyan Liu, Director, 2017-01-04
- Ltd. Pte. (Singapore) Pharma Pioneer, Large Shareholder, 2016-09-26
- Massimo Radaelli, Director, 2016-01-07
- Alex T. Mcpherson, Director, 2016-01-06
- W. David Stroman, Svp, Ophthalmic Product Devt., 2015-10-07
- J Roy Wu, Svp Bus & Corp Development, 2015-10-07
- Ramin Najafi, Chief Executive Officer, 2015-08-21
- A. Russell Hoon, Senior Vice President, 2015-04-30
- Charles Cashion, Director, 2015-01-06
- D.s. Tony Wicks, Director, 2015-01-06
- R Keith Bley, Svp Product Development, 2014-09-30
- Ltd Holdings Pharma Pioneer China, Large Shareholder, 2014-05-14
- Anthony Dailley, Director, 2014-03-21
- R. Robert Tufts, Director, 2014-02-01
- Behzad Khosrovi, Svp Product Development, 2013-01-15
- Naqu Area Pioneer Pharma Co., Ltd., Large Shareholder, 2012-11-20
- Brian Mark Anderson, Cso, 2011-11-01
- Najafi Family Trust Dated September 13, 2006, Other, 2011-08-16
- James John O'reilly, Svp Business and Corporate Dev, 2011-02-01
- Colin Scott, Vp, Clinical Research and Dev, 2011-02-01
- Jr F Harry Hixson, Director, 2010-01-05
Show All Insiders (61) Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
| 1. | | 82,795 | $123,365 | | 0% |
| 2. | | 24,795 | $36,945 | | 0% |
| 3. | | 14,604 | $21,758 | | 0% |
| 4. | | 0 | $0 | | 0% |
| 5. | | 0 | $0 | | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Large Shareholder | $0.47 | 300 | $139.50 | 1,020,300 | 2025-04-08 | Filing |
| Large Shareholder | $0.52 | 4,538 | $2,367.02 | 1,020,000 | 2025-04-04 | Filing |
| Large Shareholder | $0.56 | 22,976 | $12,928.60 | 1,015,462 | 2025-04-03 | Filing |
| Large Shareholder | $0.58 | 917 | $531.86 | 992,486 | 2025-04-02 | Filing |
| Large Shareholder | $0.59 | 19,915 | $11,650.28 | 991,569 | 2025-04-01 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Large Shareholder, Officer, Director | $1.09 | 24,720 | $26,944.80 | 22,668,516 | 2026-06-15 | Filing |
| Large Shareholder | $1.09 | 24,720 | $26,944.80 | 22,668,516 | 2026-06-15 | Filing |
| Large Shareholder | $1.09 | 24,720 | $26,944.80 | 22,668,516 | 2026-06-15 | Filing |
| Officer | $1.81 | 1 | $1.81 | 0 | 2022-12-06 | Filing |
| Officer | $1.81 | 1 | $1.81 | 0 | 2022-12-06 | Filing |
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
| 1. | | 406 | $426 | 0% |
| 2. | | 1 | $1 | 0% |
| 3. | | 1 | $1 | 0% |